MEI Pharma Inc (MEIP)
2.95
+0.05
(+1.72%)
USD |
NASDAQ |
May 31, 16:00
2.89
-0.06
(-2.03%)
After-Hours: 20:00
MEI Pharma SG&A Expense (Quarterly): 4.609M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.609M |
December 31, 2023 | 8.018M |
September 30, 2023 | 6.531M |
June 30, 2023 | 9.967M |
March 31, 2023 | 7.181M |
December 31, 2022 | 8.496M |
September 30, 2022 | 7.486M |
June 30, 2022 | 5.771M |
March 31, 2022 | 8.934M |
December 31, 2021 | 7.926M |
September 30, 2021 | 7.909M |
June 30, 2021 | 6.634M |
March 31, 2021 | 6.215M |
December 31, 2020 | 5.65M |
September 30, 2020 | 5.915M |
June 30, 2020 | 4.528M |
March 31, 2020 | 3.864M |
December 31, 2019 | 4.195M |
September 30, 2019 | 4.13M |
June 30, 2019 | 3.744M |
March 31, 2019 | 3.631M |
December 31, 2018 | 3.821M |
September 30, 2018 | 3.401M |
June 30, 2018 | 2.455M |
March 31, 2018 | 2.486M |
Date | Value |
---|---|
December 31, 2017 | 2.358M |
September 30, 2017 | 2.488M |
June 30, 2017 | 1.826M |
March 31, 2017 | 2.152M |
December 31, 2016 | 1.97M |
September 30, 2016 | 2.68M |
June 30, 2016 | 1.836M |
March 31, 2016 | 1.99M |
December 31, 2015 | 1.945M |
September 30, 2015 | 1.83M |
June 30, 2015 | 1.909M |
March 31, 2015 | 2.185M |
December 31, 2014 | 2.415M |
September 30, 2014 | 2.439M |
June 30, 2014 | 0.697M |
March 31, 2014 | 1.991M |
December 31, 2013 | 1.949M |
September 30, 2013 | 1.811M |
June 30, 2013 | 0.407M |
March 31, 2013 | 1.225M |
December 31, 2012 | 1.418M |
September 30, 2012 | 0.914M |
June 30, 2012 | 0.138M |
March 31, 2012 | 0.811M |
December 31, 2011 | 0.896M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
3.744M
Minimum
Jun 2019
9.967M
Maximum
Jun 2023
6.385M
Average
6.373M
Median
SG&A Expense (Quarterly) Benchmarks
Merck & Co Inc | 2.483B |
United Therapeutics Corp | 144.40M |
Macrogenics Inc | 14.71M |
Voyager Therapeutics Inc | 8.607M |
Moderna Inc | 274.00M |